| Literature DB >> 17971854 |
Anil S Thakur1, Gautier Robin, Gregor Guncar, Neil F W Saunders, Janet Newman, Jennifer L Martin, Bostjan Kobe.
Abstract
BACKGROUND: Crystallization is a major bottleneck in the process of macromolecular structure determination by X-ray crystallography. Successful crystallization requires the formation of nuclei and their subsequent growth to crystals of suitable size. Crystal growth generally occurs spontaneously in a supersaturated solution as a result of homogenous nucleation. However, in a typical sparse matrix screening experiment, precipitant and protein concentration are not sampled extensively, and supersaturation conditions suitable for nucleation are often missed. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2007 PMID: 17971854 PMCID: PMC2034409 DOI: 10.1371/journal.pone.0001091
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the effects of heterogenous nucleating agents.
| Protein | Control (no nucleant) | Fumed silica | CM Sephadex | Sand | Titanium(IV) oxide | Glass wool | Hydroxy-apatite | Cellulose | Horse hair | Dried seaweed | Combination of 9 nucleants | Combination of 4 nucleants | |||||||||||
| Total | + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − | |
| Lysozyme | 5 | 1 | 3 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 4 | 0 | 7 | 3 | 7 | 0 |
| Pepsin | 3 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 2 | 0 | 2 | 0 | 4 | 1 | ND | |
| Trypsin | 5 | 1 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 1 | 3 | 0 | 2 | 0 | 3 | 0 | 5 | 1 | ND | |
| Glucose Isomerase | 4 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 0 | 2 | 0 | 3 | 1 | ND | |
| Ribonuclease A | 6 | 0 | 4 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 2 | 2 | 0 | 3 | 1 | 2 | 1 | 3 | 2 | ND | |
| Myoglobin | 4 | 0 | 3 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 1 | 0 | 2 | 0 | 4 | 0 | ND | |
| α-lactalbumin | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 1 | 3 | 0 | 0 | 0 | ND | |
| Catalase | 5 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 0 | 6 | 2 | ND | |
| Xylanase | 5 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 3 | 1 | 2 | 1 | 6 | 1 | ND | |
| Thaumatin | 4 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 3 | 1 | 2 | 0 | 2 | 1 | 5 | 1 | ND | |
| Sum over all proteins | 46 | 8 | 22 | 3 | 12 | 0 | 1 | 5 | 6 | 1 | 0 | 17 | 10 | 16 | 3 | 20 | 4 | 23 | 3 | 43 | 12 | ND | |
| Total effect (crystallization hits) | −14 | −9 | −1 | −1 | 1 | 7 | 13 | 16 | 20 | 31 | ND | ||||||||||||
| Total effect (%) | −30 | −20 | −2 | −2 | 2 | 15 | 28 | 35 | 43 | 67 | ND | ||||||||||||
For each protein/heterogeneous nucleating agent pair and the sum over all proteins, the number of new and missing crystallization conditions (“+” and “−”, respectively) is shown, relative to the no-nucleant control. For the no-nucleant control, the total number of crystallization hits is shown. The total effect of the nucleating agent, relative to the no-nucleant control, is shown in the last two rows. “ND”, not determined.
Figure 1Effect of heterogenous nucleating agents.
The height of the bar represents the relative difference between the number of crystals observed in the presence and the absence of a heterogeneous nucleating agent, summed over all the proteins tested. Details of the data are presented in Table 1 and Supplementary Table S2. “Combined nucleants” refers to a mixture of all 9 nucleants.
Figure 2Example of a positive effect of a heterologous nucleating agent on crystallization.
(A) Control crystallization drop with no heterogeneous nucleating agent added (glucose isomerase, condition F4: 2% w/v polyethyleneimine, 0.1 M sodium citrate pH 5.6, 0.5 M sodium chloride). (B) Crystallization drop with identical crystallization conditions as in A, but with horse hair added as a heterogeneous nucleating agent.
Reproducibility of crystal formation.
|
|
|
|
| Lysozyme | 96 | 9.4±1.4 |
| Pepsin | 96 | 9.2±1.3 |
| Trypsin | 96 | 9.2±1.9 |
| Glucose isomerase | 96 | 8.6±1.2 |
| RNase A | 96 | 8.6±1.6 |
| Myoglobin | 96 | 8.9±1.4 |
| α-Lactalbumin | 96 | 9.4±1.4 |
| Catalase | 96 | 9.2±1.3 |
| Xylanase | 96 | 9.2±1.3 |
| Thaumatin | 96 | 9.2±1.3 |
|
| ||
| Fumed silica | 96 | 8.1±1.1 |
| CM Sephadex | 36 | 7.7±0.6 |
| Sand | - | - |
| Titanium(IV) oxide | 48 | 6.7±0.5 |
| Glass wool | - | - |
| Hydroxyapatite | 168 | 9.2±1.1 |
| Cellulose | 168 | 9.3±1.0 |
| Horse hair | 204 | 9.9±1.6 |
| Dried seaweed | 228 | 9.6±1.2 |
| Overall | 864 | 9.1±1.4 |
“-”, not applicable. Mean and standard deviation were calculated using Microsoft Excel. Twelve replicates were set up for each protein/nucleant combination tested, therefore the maximum possible number for the mean per protein/nucleant combination is 12. The no-nucleant control experiment to test reproducibility produced no crystals in any of the drops (therefore the mean±standard deviation per protein/nucleant combination for the no-nucleant control is 0. 0±0.0 in all cases).